ChiCTR2200056601 版本V1.0 版本创建时间2022/09/28 18:42:48 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2200056601 

最近更新日期:

Date of Last Refreshed on:

2022-02-09 00:06:12 

注册时间:

Date of Registration:

2022-02-09 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

肌内效贴对膝关节屈伸动作中皮肤形变影响的初步研究

Public title:

Effects of Kinesio taping on skin deformation during knee flexion and extension:A preliminary study

注册题目简写:

English Acronym:

研究课题的正式科学名称:

肌内效贴对膝关节屈伸动作中皮肤形变影响的初步研究

Scientific title:

Effects of Kinesio taping on skin deformation during knee flexion and extension:A preliminary study

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

何霏 

研究负责人:

何霏 

Applicant:

Fei He 

Study leader:

Fei He 

申请注册联系人电话:

Applicant telephone:

+86 13524052516

研究负责人电话:

Study leader's
telephone:

+86 13524052516

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

hefei111616@163.com

研究负责人电子邮件:

Study leader's E-mail:

hefei111616@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市虹口区海宁路100号

研究负责人通讯地址:

上海市虹口区海宁路100号

Applicant address:

100 Haining Road, Shanghai, China

Study leader's address:

100 Haining Road, Shanghai, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海交通大学附属第一人民医院

Applicant's institution:

Shanghai General Hospital, Shanghai Jiao Tong University

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

102772020rt028

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

上海体育学院科学研究伦理委员会

Name of the ethic committee:

Scientific Research Ethics Committee of Shanghai Sport University

伦理委员会批准日期:

Date of approved by ethic committee:

2020-05-09 00:00:00

伦理委员会联系人:

王兴放

Contact Name of the ethic committee:

Wang Xinfang

伦理委员会联系地址:

上海市杨浦区清源环路650号

Contact Address of the ethic committee:

No.650 Qingyuanhuan Road,Yangpu district,Shanghai

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海交通大学附属第一人民医院

Primary sponsor:

Shanghai General Hospital, Shanghai Jiao Tong University

研究实施负责(组长)单位地址:

上海市虹口区海宁路100号

Primary sponsor's address:

100 Haining Road, Shanghai, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海体育学院

具体地址:

上海市杨浦区清源环路650号

Institution
hospital:

Shanghai University of Sport

Address:

650 Qingyuanhuan Road,Yangpu district,Shanghai

经费或物资来源:

/

Source(s) of funding:

/

研究疾病:

/  

Target disease:

/

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

非随机对照试验 

Study design:

Non randomized control 

研究目的:

观察运动过程中的皮肤形变,分析肌内效贴对皮肤生物力学的影响,探索贴扎可能的起效机制。  

Objectives of Study:

To observe skin deformation during exercise, compare the changes with or without Kinesio tape applied using different approaches, and further analyze the effects of Kinesio taping on skin biomechanics.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

年龄20-40岁;身体健康,具有正常活动能力,无运动相关损伤,目前无髋、膝部疼痛等相关不适;无局部皮肤感染等肌内效贴扎禁忌;认知良好;自愿参加本研究,并签署知情同意书。

Inclusion criteria

(1) aged 20–40 years; (2) physically healthy; (3) able to move normally; (4) no sports-related injuries; (5) no hip pain, knee pain, or other related discomfort; (6) no local skin infections or other contraindications to Kinesio taping; and (7) no cognitive impairment.

排除标准:

伴有心血管疾病、神经疾病或精神疾病以及严重的视觉或听觉障碍;伴有脊柱(脊椎椎间盘突出、脊柱手术等)和四肢(如骨折、假体、骨关节炎等)等骨科疾病的患者。

Exclusion criteria:

(1) patients with cardiovascular, neurological, or psychiatric disease or severe visual or hearing impairment; and (2) patients with orthopedic disease of the spine (e.g., spinal sac herniation) or extremities (e.g., fractures, prostheses, osteoarthritis).

研究实施时间:

Study execute time:

From 2020-10-01 00:00:00 To 2021-03-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-10-01 00:00:00 To 2021-03-31 00:00:00

干预措施:

Interventions:

组别:

试验组

样本量:

10

Group:

experimental group

Sample size:

干预措施:

肌内效贴

干预措施代码:

Intervention:

Kinesio Tape

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

上海体育学院 

单位级别:

Institution
hospital:

Shanghai University of Sport

Level of the institution:

/

测量指标:

Outcomes:

指标中文名:

右大腿前侧皮肤表面观察区域长度

指标类型:

主要指标

Outcome:

Skin surface on the right anterior thigh on right knee

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age 20 years
最大 Max age 40 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

/

Randomization Procedure (please state who generates the random number sequence and by what method):

/

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

公开在百度云网盘http://pan.baidu.com/share/manage; ResMan

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

http://pan.baidu.com/share/manage; ResMan

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

采用CRF进行数据记录,并使用电子管理系统进行数据管理

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

we use CRF and EDC to collect and manage data

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2022-02-09 00:06:12